Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CGAU | SSRM |
|---|---|---|
| Price | $21.69 | $34.28 |
| Change today | ▲ 0.60% | ▲ 1.09% |
| Market cap | $4.24B | $6.99B |
| Return, 3 months | +39.2% | +21.7% |
| Return, year to date | +52.2% | +56.5% |
| Return, 1 year | +91.7% | +47.6% |
| P/E (TTM) | 6.9 | 30.9 |
| P/B | 2.0 | 2.1 |
| P/E percentile vs own 5y | 62nd | 95th |
| Dividend yield | 0.93% | – |
| Revenue growth (YoY, latest qtr) | +53.5% | +9.5% |
| Net profit growth (YoY) | +5.2% | +15.0% |
| Gross margin | 38.1% | 56.4% |
| Operating margin | 27.1% | 35.1% |
| Net margin | 36.9% | 12.3% |
| Return on equity | 32.9% | 7.1% |
| Analyst target vs. price | +8.8% | +25.0% |
| Analyst buy share | 60% | 100% |
| RSI (14) | 46 | 47 |
| 30-day volatility | 37.2% | 46.1% |
| Max drawdown, 1 year | -29.5% | -31.3% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
